This is a Validated Antibody Database (VAD) review about cow MAPK1, based on 60 published articles (read how Labome selects the articles), using MAPK1 antibody in all methods. It is aimed to help Labome visitors find the most suited MAPK1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
MAPK1 synonym: ERK2; mitogen-activated protein kinase 1; ERK-2; ERT1; MAP kinase 1; MAP kinase 2; MAPK 1; MAPK 2; extracellular signal-regulated kinase 2; mitogen-activated protein kinase 2; p42-MAPK

Invitrogen
rabbit polyclonal
  • western blot; rat; loading ...; fig 4b
Invitrogen MAPK1 antibody (Thermo Fisher Scientific, 44-654G) was used in western blot on rat samples (fig 4b). Biosci Rep (2018) ncbi
rabbit polyclonal
  • western blot; human; loading ...; fig 1d
In order to characterize a new specific pharmacological hematopoietic cell kinase inhibitor, Invitrogen MAPK1 antibody (Invitrogen, 44-680G) was used in western blot on human samples (fig 1d). Biochim Biophys Acta Mol Basis Dis (2017) ncbi
rabbit polyclonal
  • western blot; human; loading ...; fig 1d
In order to characterize a new specific pharmacological hematopoietic cell kinase inhibitor, Invitrogen MAPK1 antibody (Invitrogen, 44-654G) was used in western blot on human samples (fig 1d). Biochim Biophys Acta Mol Basis Dis (2017) ncbi
rabbit polyclonal
  • western blot; human; loading ...; fig 1b
In order to compare dabrafenib-resistant and -sensitive BRAF-mutant human melanoma cell lines, Invitrogen MAPK1 antibody (Invitrogen, 44-680G) was used in western blot on human samples (fig 1b). Int J Oncol (2016) ncbi
rabbit polyclonal
  • western blot; mouse; loading ...; fig 5e
  • western blot; human; loading ...; fig s3b
In order to discover that WNK1 kinase regulates integrin-mediated adhesion and T cell migration, Invitrogen MAPK1 antibody (Life Technologies, 44-680G) was used in western blot on mouse samples (fig 5e) and in western blot on human samples (fig s3b). Nat Immunol (2016) ncbi
rabbit polyclonal
  • western blot; mouse; loading ...; fig 5e
  • western blot; human; loading ...; fig s3b
In order to discover that WNK1 kinase regulates integrin-mediated adhesion and T cell migration, Invitrogen MAPK1 antibody (Life Technologies, 44-654G) was used in western blot on mouse samples (fig 5e) and in western blot on human samples (fig s3b). Nat Immunol (2016) ncbi
rabbit polyclonal
  • western blot; human; fig 3
In order to research pediatric large congenital melanocytic nevi to show melanocytes affect nodal expression and signaling in melanoma cells, Invitrogen MAPK1 antibody (Life technologies, 44-654-G) was used in western blot on human samples (fig 3). Int J Mol Sci (2016) ncbi
rabbit polyclonal
  • western blot; human; fig 4
In order to determine facilitation of chemoresistance and cancer proliferation by Haem-dependent dimerization of PGRMC1/Sigma-2 receptor, Invitrogen MAPK1 antibody (Invitrogen, 44680G) was used in western blot on human samples (fig 4). Nat Commun (2016) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; human; fig 3
  • western blot; human; fig 1
In order to learn how oncogene addiction can be broken in tumors with MET amplification by the Anti-c-Met monoclonal antibody ABT-700, Invitrogen MAPK1 antibody (Invitrogen, 44680G) was used in immunohistochemistry - paraffin section on human samples (fig 3) and in western blot on human samples (fig 1). BMC Cancer (2016) ncbi
rabbit polyclonal
  • western blot; human; fig 6
In order to determine a mechanism for regulation of tumor progression due to simultaneous activation of induced heterodimerization between cannabinoid receptor 2 (CB2) and CXCR4 chemokine receptor, Invitrogen MAPK1 antibody (Invitrogen Biosource, 44-654G) was used in western blot on human samples (fig 6). J Biol Chem (2016) ncbi
rabbit polyclonal
  • western blot; rat; fig 5
In order to investigate the role of neuron-enriched Na(+)/H(+) exchanger NHE5, Invitrogen MAPK1 antibody (Invitrogen, 44-680G) was used in western blot on rat samples (fig 5). Mol Biol Cell (2016) ncbi
rabbit polyclonal
  • western blot; human; 1:1000; fig 3
In order to test if DEHP affects MMP-2 or MMP-9 expression in vascular smooth muscle cells, Invitrogen MAPK1 antibody (Invitrogen, 44680G) was used in western blot on human samples at 1:1000 (fig 3). Int J Mol Sci (2015) ncbi
rabbit polyclonal
  • western blot; human; fig 3
In order to study how all-trans retinoic acid modulates the ERK signaling pathway, Invitrogen MAPK1 antibody (Thermo Fisher Scientific, 44-680G) was used in western blot on human samples (fig 3). Biomed Res Int (2015) ncbi
rabbit polyclonal
  • western blot; human
In order to assess the use of 3D1 mAb for treating Nodal expressing cancers, Invitrogen MAPK1 antibody (Life Technologies, 44-654-G) was used in western blot on human samples . Oncotarget (2015) ncbi
rabbit polyclonal
  • western blot; human; fig 1
In order to show that inhibition of the oxidative arm of the pentose phosphate pathway is required for antimalarial-mediated apoptosis, Invitrogen MAPK1 antibody (Invitrogen, 44-680G) was used in western blot on human samples (fig 1). Oncogene (2016) ncbi
rabbit polyclonal
  • western blot; human; 1:1000
In order to test if NBDHEX and MC3181 have antitumor activity against melanoma cells resistant to vemurafenib, Invitrogen MAPK1 antibody (Invitrogen, 44680G) was used in western blot on human samples at 1:1000. Biochem Pharmacol (2015) ncbi
rabbit polyclonal
  • immunocytochemistry; rat; fig 1
In order to describe a method for the preparation, fixation, and fluorescence analysis of in vitro cultivated metacestode vesicles from E. multilocularis, Invitrogen MAPK1 antibody (Life Technologies, 44680G) was used in immunocytochemistry on rat samples (fig 1). PLoS ONE (2015) ncbi
rabbit polyclonal
  • western blot; mouse; 1:2000; fig 5b
In order to uncover a role for ATG12-ATG3 in late endosome function that is distinct from autophagy, Invitrogen MAPK1 antibody (Biosource, 44-680G) was used in western blot on mouse samples at 1:2000 (fig 5b). Nat Cell Biol (2015) ncbi
rabbit polyclonal
  • western blot; human; fig 4
In order to elucidate the tumor suppressor function of BTG3, Invitrogen MAPK1 antibody (Invitrogen Life Technologies, 44680G) was used in western blot on human samples (fig 4). Cell Death Dis (2015) ncbi
rabbit polyclonal
  • western blot; human; fig 4
In order to elucidate the tumor suppressor function of BTG3, Invitrogen MAPK1 antibody (Invitrogen Life Technologies, 44-654G) was used in western blot on human samples (fig 4). Cell Death Dis (2015) ncbi
rabbit monoclonal (K.913.4)
  • immunohistochemistry - paraffin section; zebrafish
  • western blot; zebrafish
In order to show that H2O2 acts via MAPK signaling for heart regeneration in adult zebrafish, Invitrogen MAPK1 antibody (Pierce, MA5-15134) was used in immunohistochemistry - paraffin section on zebrafish samples and in western blot on zebrafish samples . Cell Res (2014) ncbi
rabbit polyclonal
  • immunohistochemistry; human; 1:50; fig 6
  • western blot; human; 1:1000; fig 4
In order to assess the role of the MEK1/2-ERK1/2 signaling pathway in the pathogenesis of chronic rhinosinusitis with nasal polyps, Invitrogen MAPK1 antibody (Invitrogen, 44-680G) was used in immunohistochemistry on human samples at 1:50 (fig 6) and in western blot on human samples at 1:1000 (fig 4). Arch Immunol Ther Exp (Warsz) (2014) ncbi
rabbit polyclonal
  • western blot; human; 1:1000
In order to test if extracellular signal-regulated kinase and c-Jun N-terminal kinase are associated with long-term organ damage in SLE patients, Invitrogen MAPK1 antibody (BioSource, 44-654G) was used in western blot on human samples at 1:1000. Rheumatology (Oxford) (2014) ncbi
rabbit polyclonal
  • western blot; human; 1:1000
In order to test if extracellular signal-regulated kinase and c-Jun N-terminal kinase are associated with long-term organ damage in SLE patients, Invitrogen MAPK1 antibody (BioSource, 44-680G) was used in western blot on human samples at 1:1000. Rheumatology (Oxford) (2014) ncbi
rabbit polyclonal
  • western blot; human; fig 7
In order to alter the C-terminal trafficking domain of P2X7 and examine its function, Invitrogen MAPK1 antibody (Invitrogen, 44680G) was used in western blot on human samples (fig 7). PLoS ONE (2013) ncbi
rabbit polyclonal
  • western blot; human
In order to identify Lyn as a redox sensor that recruits neutrophils to wounds in zebrafish larvae, Invitrogen MAPK1 antibody (BioSource, 44654G) was used in western blot on human samples . Nature (2011) ncbi
rabbit polyclonal
  • immunocytochemistry; Caenorhabditis elegans; fig 7
In order to identify and characterize the role of TFG-1 in protein secretion and export of cargo from the endoplasmic reticulum, Invitrogen MAPK1 antibody (Invitrogen, 44680G) was used in immunocytochemistry on Caenorhabditis elegans samples (fig 7). Nat Cell Biol (2011) ncbi
rabbit polyclonal
  • western blot; human; fig 3
In order to investigate the roles of EGFR and beta1 integrin in ErbB2-driven anchorage independence of tumor cells, Invitrogen MAPK1 antibody (Invitrogen, 44-680G) was used in western blot on human samples (fig 3). J Biol Chem (2011) ncbi
rabbit polyclonal
  • immunohistochemistry; human; 0.5 ug/ul; fig 1
In order to develop an in vitro model for experimental studies of cancer cell invasion, Invitrogen MAPK1 antibody (Biosource, 44-680G) was used in immunohistochemistry on human samples at 0.5 ug/ul (fig 1). Eur J Oral Sci (2010) ncbi
rabbit polyclonal
  • immunocytochemistry; rat; 1:50; fig 3
  • western blot; rat; fig 3
In order to investigate the potential neuroprotective effects of extranuclear estrogen receptors in the brain following cerebral ischemia, Invitrogen MAPK1 antibody (Biosource, 44-680G) was used in immunocytochemistry on rat samples at 1:50 (fig 3) and in western blot on rat samples (fig 3). PLoS ONE (2010) ncbi
rabbit polyclonal
  • western blot; human; 1:1000; fig 1
In order to examine how PDK1 affects MAPK and PI3K signaling in tumor cells, Invitrogen MAPK1 antibody (Invitrogen, 44680G) was used in western blot on human samples at 1:1000 (fig 1). Mol Cancer Res (2010) ncbi
rabbit polyclonal
In order to elucidate the mechanisms by which loss of Cav1 function promotes cancer cell growth, Invitrogen MAPK1 antibody (Biosource, 44-680G) was used . Mol Cell Biol (2009) ncbi
rabbit polyclonal
In order to elucidate the mechanisms by which loss of Cav1 function promotes cancer cell growth, Invitrogen MAPK1 antibody (Biosource, 44-654G) was used . Mol Cell Biol (2009) ncbi
rabbit polyclonal
  • western blot; human; fig 3
In order to discuss the contribution of the p21ras/MAP kinase pathway to systemic lupus erythematosus, Invitrogen MAPK1 antibody (Bio-Source, 44-654G) was used in western blot on human samples (fig 3). Ann Rheum Dis (2010) ncbi
rabbit polyclonal
In order to assess the prognostic value of activated phosphorylated ERK1 and ERK2 and COX-2 at the invasive front and in central/superficial parts of oral squamous cell carcinomas, Invitrogen MAPK1 antibody (BioSource, 44-680G) was used . J Oral Pathol Med (2008) ncbi
rabbit polyclonal
In order to develop an assay to measure temporal, site-specific phosphorylation of key members of the EGFR pathway in A431 cells stimulated with epidermal growth factor, Invitrogen MAPK1 antibody (Invitrogen, 44-680G) was used . Anal Biochem (2008) ncbi
rabbit polyclonal
In order to study the role of laminins during osteogenic differentiation of human mesenchymal stem cells, Invitrogen MAPK1 antibody (Biosource, 44-680) was used . Exp Cell Res (2008) ncbi
rabbit polyclonal
In order to report that FAK is an important mediator of laminin-5-induced osteogenic differentiation of human mesenchymal stem cells, Invitrogen MAPK1 antibody (Biosource, 44-680G) was used . J Cell Biochem (2007) ncbi
rabbit polyclonal
In order to report that epidermal growth factor treatment induced Erk1/2 phosphorylation in rat suprachiasmatic nucleus cells, Invitrogen MAPK1 antibody (Biosources, 44-680G) was used . Brain Res (2006) ncbi
rabbit polyclonal
In order to assess the contribution of CCL2/CCR2 signaling to systemic sclerosis, Invitrogen MAPK1 antibody (BioSource, 44-680G) was used . Arthritis Rheum (2005) ncbi
Abcam
rabbit polyclonal
  • western blot; human; loading ...; fig 5b
Abcam MAPK1 antibody (Abcam, ab115799) was used in western blot on human samples (fig 5b). Eur Rev Med Pharmacol Sci (2019) ncbi
rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 6a
Abcam MAPK1 antibody (Abcam, ab17942) was used in western blot on human samples at 1:1000 (fig 6a). Lab Invest (2019) ncbi
rabbit polyclonal
  • western blot; human; 1:100; loading ...; fig 5a
Abcam MAPK1 antibody (Abcam, ab17942) was used in western blot on human samples at 1:100 (fig 5a). Exp Ther Med (2017) ncbi
mouse monoclonal (MAPK-YT)
  • immunocytochemistry; human; 1:200; loading ...; fig 6d
In order to study H2O2-dependent wound repair mechanisms in human keratinocytes, Abcam MAPK1 antibody (Abcam, ab50011) was used in immunocytochemistry on human samples at 1:200 (fig 6d). J Cell Sci (2017) ncbi
rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 4a
Abcam MAPK1 antibody (Abcam, ab17942) was used in western blot on human samples at 1:1000 (fig 4a). Oncotarget (2017) ncbi
rabbit polyclonal
  • western blot; rat; loading ...
Abcam MAPK1 antibody (Abcam, Ab17942) was used in western blot on rat samples . PLoS ONE (2016) ncbi
mouse monoclonal (MAPK-YT)
  • western blot; rat; loading ...
Abcam MAPK1 antibody (Abcam, Ab50011) was used in western blot on rat samples . PLoS ONE (2016) ncbi
rabbit polyclonal
  • western blot; human; fig 6
Abcam MAPK1 antibody (Abcam, ab17942) was used in western blot on human samples (fig 6). Sci Rep (2016) ncbi
mouse monoclonal (MAPK-YT)
  • western blot; human; fig 6
Abcam MAPK1 antibody (Abcam, ab50011) was used in western blot on human samples (fig 6). Sci Rep (2016) ncbi
rabbit polyclonal
  • western blot; rat; fig 4
Abcam MAPK1 antibody (Abcam, ab17942) was used in western blot on rat samples (fig 4). Mol Brain (2016) ncbi
rabbit polyclonal
  • western blot; chicken; 1:200; loading ...; fig 2b
In order to study the effects of inorganic and organic Mn sources on MnSOD mRNA, protein, and enzymatic activity, Abcam MAPK1 antibody (Abcam, ab79853) was used in western blot on chicken samples at 1:200 (fig 2b). Biometals (2016) ncbi
rabbit polyclonal
  • immunocytochemistry; human; fig 2
Abcam MAPK1 antibody (AbCam, Ab17942) was used in immunocytochemistry on human samples (fig 2). Cancer Biol Ther (2016) ncbi
mouse monoclonal (MAPK-YT)
  • immunocytochemistry; human; fig 2
  • western blot; human; fig 5
Abcam MAPK1 antibody (AbCam, Ab50011) was used in immunocytochemistry on human samples (fig 2) and in western blot on human samples (fig 5). Cancer Biol Ther (2016) ncbi
mouse monoclonal (MAPK-YT)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 2
In order to correlate expression of proteins in ErbB family signaling pathways with the clinical efficacy of lapatinib, Abcam MAPK1 antibody (Abcam, ab50011) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2). Oncotarget (2016) ncbi
rabbit polyclonal
  • western blot; human; loading ...; fig 1d
Abcam MAPK1 antibody (abcam, 115799) was used in western blot on human samples (fig 1d). Mar Drugs (2015) ncbi
mouse monoclonal (MAPK-YT)
  • western blot; human; loading ...; fig 1d
Abcam MAPK1 antibody (abcam, 50011) was used in western blot on human samples (fig 1d). Mar Drugs (2015) ncbi
rabbit polyclonal
  • immunocytochemistry; mouse; 1:200; fig 3
Abcam MAPK1 antibody (Abcam, ab17942) was used in immunocytochemistry on mouse samples at 1:200 (fig 3). PLoS ONE (2015) ncbi
mouse monoclonal (MAPK-YT)
  • immunohistochemistry; human; fig 1
Abcam MAPK1 antibody (abcam, ab50011) was used in immunohistochemistry on human samples (fig 1). Mol Cancer (2015) ncbi
rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 4d
Abcam MAPK1 antibody (Abcam, ab17942) was used in western blot on human samples at 1:1000 (fig 4d). Oncotarget (2015) ncbi
rabbit polyclonal
  • western blot; mouse; 1:1000; fig 4a,b
Abcam MAPK1 antibody (Abcam, ab17942) was used in western blot on mouse samples at 1:1000 (fig 4a,b). PLoS ONE (2015) ncbi
mouse monoclonal (MAPK-YT)
  • western blot; human; fig 6
Abcam MAPK1 antibody (Abcam, ab50011) was used in western blot on human samples (fig 6). Biomaterials (2015) ncbi
mouse monoclonal (MAPK-YT)
  • western blot; human; loading ...; fig 2a
Abcam MAPK1 antibody (Abcam, ab50011) was used in western blot on human samples (fig 2a). Med Oncol (2015) ncbi
mouse monoclonal (MAPK-YT)
  • immunohistochemistry - paraffin section; zebrafish ; 1:300
In order to study the relationship between two neutrophil chemoattractants, DUOX1-derived hydrogen peroxide and CXCL8, Abcam MAPK1 antibody (Abcam, ab50011) was used in immunohistochemistry - paraffin section on zebrafish samples at 1:300. J Immunol (2015) ncbi
rabbit polyclonal
  • western blot; mouse; 1:5000; loading ...; fig 3A
Abcam MAPK1 antibody (Abcam, ab17942) was used in western blot on mouse samples at 1:5000 (fig 3A). Biochimie (2015) ncbi
rabbit polyclonal
  • western blot; human; fig s4
Abcam MAPK1 antibody (Abcam, ab17942) was used in western blot on human samples (fig s4). J Cell Sci (2015) ncbi
mouse monoclonal (MAPK-YT)
  • immunohistochemistry; rat; 1:200
Abcam MAPK1 antibody (Abcam, ab50011) was used in immunohistochemistry on rat samples at 1:200. J Surg Res (2014) ncbi
rabbit polyclonal
  • western blot; cow; fig 5, 6
In order to study the role of TLR-1, -2 and -6 on bovine endometrial stromal and epithelial cells in the immune and inflammatory responses to bacterial lipopeptides, Abcam MAPK1 antibody (Abcam, AB17942) was used in western blot on cow samples (fig 5, 6). Endocrinology (2014) ncbi
mouse monoclonal (MAPK-YT)
  • western blot; human; 1:50-500
Abcam MAPK1 antibody (Abcam, ab50011) was used in western blot on human samples at 1:50-500. Reprod Biol Endocrinol (2013) ncbi
mouse monoclonal (MAPK-YT)
  • immunohistochemistry; human; 1:200
Abcam MAPK1 antibody (Abcam, ab50011) was used in immunohistochemistry on human samples at 1:200. PLoS ONE (2013) ncbi
GeneTex
rabbit polyclonal
  • western blot; human; loading ...; fig 1b
In order to compare dabrafenib-resistant and -sensitive BRAF-mutant human melanoma cell lines, GeneTex MAPK1 antibody (GeneTex, GTX17942) was used in western blot on human samples (fig 1b). Int J Oncol (2016) ncbi
rabbit polyclonal
  • western blot; human; 1:1000
In order to test if NBDHEX and MC3181 have antitumor activity against melanoma cells resistant to vemurafenib, GeneTex MAPK1 antibody (Genetex, GTX17942) was used in western blot on human samples at 1:1000. Biochem Pharmacol (2015) ncbi
Articles Reviewed
  1. Zhao J, Sun H, Zhang J, Wang M, Du X, Zhang J. Long non-coding RNA ANRIL down-regulates microRNA-7 to protect human trabecular meshwork cells in an experimental model for glaucoma. Eur Rev Med Pharmacol Sci. 2019;23:3173-3182 pubmed publisher
  2. Dai L, Hu W, Yang Z, Chen D, He B, Chen Y, et al. Upregulated expression of HOXB7 in intrahepatic cholangiocarcinoma is associated with tumor cell metastasis and poor prognosis. Lab Invest. 2019;99:736-748 pubmed publisher
  3. Ahmad F, Salahuddin M, Alsamman K, Herzallah H, Al Otaibi S. Neonatal maternal deprivation impairs localized de novo activity-induced protein translation at the synapse in the rat hippocampus. Biosci Rep. 2018;38: pubmed publisher
  4. He L, Zhang L, Wang M, Wang W. miR-9 functions as a tumor inhibitor of cell proliferation in epithelial ovarian cancer through targeting the SDF-1/CXCR4 pathway. Exp Ther Med. 2017;13:1203-1208 pubmed publisher
  5. Lisse T, Rieger S. IKKα regulates human keratinocyte migration through surveillance of the redox environment. J Cell Sci. 2017;130:975-988 pubmed publisher
  6. Fourneaux B, Chaire V, Lucchesi C, Karanian M, Pineau R, Laroche Clary A, et al. Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical implications. Oncotarget. 2017;8:7878-7890 pubmed publisher
  7. Roversi F, Pericole F, Machado Neto J, da Silva Santos Duarte A, Longhini A, Corrocher F, et al. Hematopoietic cell kinase (HCK) is a potential therapeutic target for dysplastic and leukemic cells due to integration of erythropoietin/PI3K pathway and regulation of erythropoiesis: HCK in erythropoietin/PI3K pathway. Biochim Biophys Acta Mol Basis Dis. 2017;1863:450-461 pubmed publisher
  8. Caporali S, Alvino E, Lacal P, Levati L, Giurato G, Memoli D, et al. Targeting the PI3K/AKT/mTOR pathway overcomes the stimulating effect of dabrafenib on the invasive behavior of melanoma cells with acquired resistance to the BRAF inhibitor. Int J Oncol. 2016;49:1164-74 pubmed publisher
  9. Ruess D, Probst M, Marjanovic G, Wittel U, Hopt U, Keck T, et al. HDACi Valproic Acid (VPA) and Suberoylanilide Hydroxamic Acid (SAHA) Delay but Fail to Protect against Warm Hepatic Ischemia-Reperfusion Injury. PLoS ONE. 2016;11:e0161233 pubmed publisher
  10. Köchl R, Thelen F, Vanes L, Brazão T, Fountain K, Xie J, et al. WNK1 kinase balances T cell adhesion versus migration in vivo. Nat Immunol. 2016;17:1075-83 pubmed publisher
  11. Zhao Y, Li Y, Luo P, Gao Y, Yang J, Lao K, et al. XBP1 splicing triggers miR-150 transfer from smooth muscle cells to endothelial cells via extracellular vesicles. Sci Rep. 2016;6:28627 pubmed publisher
  12. Zhai W, Chen D, Shen H, Chen Z, Li H, Yu Z, et al. A1 adenosine receptor attenuates intracerebral hemorrhage-induced secondary brain injury in rats by activating the P38-MAPKAP2-Hsp27 pathway. Mol Brain. 2016;9:66 pubmed publisher
  13. Margaryan N, Gilgur A, Seftor E, Purnell C, Arva N, Gosain A, et al. Melanocytes Affect Nodal Expression and Signaling in Melanoma Cells: A Lesson from Pediatric Large Congenital Melanocytic Nevi. Int J Mol Sci. 2016;17:418 pubmed publisher
  14. Kabe Y, Nakane T, Koike I, Yamamoto T, Sugiura Y, Harada E, et al. Haem-dependent dimerization of PGRMC1/Sigma-2 receptor facilitates cancer proliferation and chemoresistance. Nat Commun. 2016;7:11030 pubmed publisher
  15. Wang J, Goetsch L, Tucker L, Zhang Q, Gonzalez A, Vaidya K, et al. Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification. BMC Cancer. 2016;16:105 pubmed publisher
  16. Li S, Lu L, Liao X, Gao T, Wang F, Zhang L, et al. Manganese elevates manganese superoxide dismutase protein level through protein kinase C and protein tyrosine kinase. Biometals. 2016;29:265-74 pubmed publisher
  17. Coke C, Scarlett K, Chetram M, Jones K, Sandifer B, Davis A, et al. Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine Receptor and Cannabinoid Receptor 2 (CB2) Reveals a Mechanism for Regulation of Tumor Progression. J Biol Chem. 2016;291:9991-10005 pubmed publisher
  18. Dorris E, Blackshields G, Sommerville G, Alhashemi M, Dias A, McEneaney V, et al. Pluripotency markers are differentially induced by MEK inhibition in thyroid and melanoma BRAFV600E cell lines. Cancer Biol Ther. 2016;17:526-42 pubmed publisher
  19. Fan S, Numata Y, Numata M. Endosomal Na+/H+ exchanger NHE5 influences MET recycling and cell migration. Mol Biol Cell. 2016;27:702-15 pubmed publisher
  20. Shih M, Pan K, Cherng J. Possible Mechanisms of Di(2-ethylhexyl) Phthalate-Induced MMP-2 and MMP-9 Expression in A7r5 Rat Vascular Smooth Muscle Cells. Int J Mol Sci. 2015;16:28800-11 pubmed publisher
  21. Duchnowska R, Wysocki P, Korski K, Czartoryska Arłukowicz B, Niwińska A, Orlikowska M, et al. Immunohistochemical prediction of lapatinib efficacy in advanced HER2-positive breast cancer patients. Oncotarget. 2016;7:550-64 pubmed publisher
  22. Ampofo E, Später T, Müller I, Eichler H, Menger M, Laschke M. The Marine-Derived Kinase Inhibitor Fascaplysin Exerts Anti-Thrombotic Activity. Mar Drugs. 2015;13:6774-91 pubmed publisher
  23. Quintero Barceinas R, García Regalado A, Aréchaga Ocampo E, Villegas Sepúlveda N, González De la Rosa C. All-Trans Retinoic Acid Induces Proliferation, Survival, and Migration in A549 Lung Cancer Cells by Activating the ERK Signaling Pathway through a Transcription-Independent Mechanism. Biomed Res Int. 2015;2015:404368 pubmed publisher
  24. Sipieter F, Cappe B, Gonzalez Pisfil M, Spriet C, Bodart J, Cailliau Maggio K, et al. Novel Reporter for Faithful Monitoring of ERK2 Dynamics in Living Cells and Model Organisms. PLoS ONE. 2015;10:e0140924 pubmed publisher
  25. Bauer J, Ozden O, Akagi N, Carroll T, Principe D, Staudacher J, et al. Activin and TGFβ use diverging mitogenic signaling in advanced colon cancer. Mol Cancer. 2015;14:182 pubmed publisher
  26. Strizzi L, Sandomenico A, Margaryan N, Focà A, Sanguigno L, Bodenstine T, et al. Effects of a novel Nodal-targeting monoclonal antibody in melanoma. Oncotarget. 2015;6:34071-86 pubmed publisher
  27. Salas E, Roy S, Marsh T, Rubin B, Debnath J. Oxidative pentose phosphate pathway inhibition is a key determinant of antimalarial induced cancer cell death. Oncogene. 2016;35:2913-22 pubmed publisher
  28. Gu Y, Li H, Zhao L, Zhao S, He W, Rui L, et al. GRP78 confers the resistance to 5-FU by activating the c-Src/LSF/TS axis in hepatocellular carcinoma. Oncotarget. 2015;6:33658-74 pubmed publisher
  29. Liu J, Zhang X, Zhang W, Gu G, Wang P. Effects of Sevoflurane on Young Male Adult C57BL/6 Mice Spatial Cognition. PLoS ONE. 2015;10:e0134217 pubmed publisher
  30. Bhang S, Han J, Jang H, Noh M, La W, Yi M, et al. pH-triggered release of manganese from MnAu nanoparticles that enables cellular neuronal differentiation without cellular toxicity. Biomaterials. 2015;55:33-43 pubmed publisher
  31. Graziani G, Artuso S, De Luca A, Muzi A, Rotili D, Scimeca M, et al. A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib. Biochem Pharmacol. 2015;95:16-27 pubmed publisher
  32. Cheng Z, Liu F, Zhu S, Tian H, Wang L, Wang Y. A rapid and convenient method for fluorescence analysis of in vitro cultivated metacestode vesicles from Echinococcus multilocularis. PLoS ONE. 2015;10:e0118215 pubmed publisher
  33. Murrow L, Malhotra R, Debnath J. ATG12-ATG3 interacts with Alix to promote basal autophagic flux and late endosome function. Nat Cell Biol. 2015;17:300-10 pubmed publisher
  34. Bai L, Mao R, Wang J, Ding L, Jiang S, Gao C, et al. ERK1/2 promoted proliferation and inhibited apoptosis of human cervical cancer cells and regulated the expression of c-Fos and c-Jun proteins. Med Oncol. 2015;32:57 pubmed publisher
  35. de Oliveira S, Boudinot P, Calado Ã, Mulero V. Duox1-derived H2O2 modulates Cxcl8 expression and neutrophil recruitment via JNK/c-JUN/AP-1 signaling and chromatin modifications. J Immunol. 2015;194:1523-33 pubmed publisher
  36. Gao B, Huang Q, Jie Q, Wang L, Zhang H, Liu J, et al. Dose-response estrogen promotes osteogenic differentiation via GPR40 (FFAR1) in murine BMMSCs. Biochimie. 2015;110:36-44 pubmed publisher
  37. Cheng Y, Chen P, Chiang H, Suen C, Hwang M, Lin T, et al. Candidate tumor suppressor B-cell translocation gene 3 impedes neoplastic progression by suppression of AKT. Cell Death Dis. 2015;6:e1584 pubmed publisher
  38. Diesenberg K, Beerbaum M, Fink U, Schmieder P, Krauss M. SEPT9 negatively regulates ubiquitin-dependent downregulation of EGFR. J Cell Sci. 2015;128:397-407 pubmed publisher
  39. Han P, Zhou X, Chang N, Xiao C, Yan S, Ren H, et al. Hydrogen peroxide primes heart regeneration with a derepression mechanism. Cell Res. 2014;24:1091-107 pubmed publisher
  40. Tsai Y, Wang C, Leung P, Lin K, Chio C, Hu C, et al. Extracellular signal-regulated kinase 1/2 is involved in a tamoxifen neuroprotective effect in a lateral fluid percussion injury rat model. J Surg Res. 2014;189:106-16 pubmed publisher
  41. Linke R, Pries R, Könnecke M, Bruchhage K, Böscke R, Gebhard M, et al. The MEK1/2-ERK1/2 pathway is activated in chronic rhinosinusitis with nasal polyps. Arch Immunol Ther Exp (Warsz). 2014;62:217-29 pubmed publisher
  42. Bloch O, Amit Vazina M, Yona E, Molad Y, Rapoport M. Increased ERK and JNK activation and decreased ERK/JNK ratio are associated with long-term organ damage in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2014;53:1034-42 pubmed
  43. Turner M, Cronin J, Healey G, Sheldon I. Epithelial and stromal cells of bovine endometrium have roles in innate immunity and initiate inflammatory responses to bacterial lipopeptides in vitro via Toll-like receptors TLR2, TLR1, and TLR6. Endocrinology. 2014;155:1453-65 pubmed publisher
  44. O Brien M, Carbin S, Morrison J, Smith T. Decreased myometrial p160 ROCK-1 expression in obese women at term pregnancy. Reprod Biol Endocrinol. 2013;11:79 pubmed publisher
  45. Wickert L, Blanchette J, Waldschmidt N, Bertics P, Denu J, Denlinger L, et al. The C-terminus of human nucleotide receptor P2X7 is critical for receptor oligomerization and N-linked glycosylation. PLoS ONE. 2013;8:e63789 pubmed publisher
  46. Ahnstedt H, Cao L, Krause D, Warfvinge K, Saveland H, Nilsson O, et al. Male-female differences in upregulation of vasoconstrictor responses in human cerebral arteries. PLoS ONE. 2013;8:e62698 pubmed publisher
  47. Yoo S, Starnes T, Deng Q, Huttenlocher A. Lyn is a redox sensor that mediates leukocyte wound attraction in vivo. Nature. 2011;480:109-12 pubmed publisher
  48. Witte K, Schuh A, Hegermann J, Sarkeshik A, Mayers J, Schwarze K, et al. TFG-1 function in protein secretion and oncogenesis. Nat Cell Biol. 2011;13:550-8 pubmed publisher
  49. Grassian A, Schafer Z, Brugge J. ErbB2 stabilizes epidermal growth factor receptor (EGFR) expression via Erk and Sprouty2 in extracellular matrix-detached cells. J Biol Chem. 2011;286:79-90 pubmed publisher
  50. Brusevold I, Husvik C, Schreurs O, Schenck K, Bryne M, Søland T. Induction of invasion in an organotypic oral cancer model by CoCl2, a hypoxia mimetic. Eur J Oral Sci. 2010;118:168-76 pubmed publisher
  51. Yang L, Zhang Q, Zhou C, Yang F, Zhang Y, Wang R, et al. Extranuclear estrogen receptors mediate the neuroprotective effects of estrogen in the rat hippocampus. PLoS ONE. 2010;5:e9851 pubmed publisher
  52. Lu Z, Cox Hipkin M, Windsor W, Boyapati A. 3-phosphoinositide-dependent protein kinase-1 regulates proliferation and survival of cancer cells with an activated mitogen-activated protein kinase pathway. Mol Cancer Res. 2010;8:421-32 pubmed publisher
  53. Cerezo A, Guadamillas M, Goetz J, Sánchez Perales S, Klein E, Assoian R, et al. The absence of caveolin-1 increases proliferation and anchorage- independent growth by a Rac-dependent, Erk-independent mechanism. Mol Cell Biol. 2009;29:5046-59 pubmed publisher
  54. Molad Y, Amit Vasina M, Bloch O, Yona E, Rapoport M. Increased ERK and JNK activities correlate with disease activity in patients with systemic lupus erythematosus. Ann Rheum Dis. 2010;69:175-80 pubmed publisher
  55. Søland T, Husvik C, Koppang H, Boysen M, Sandvik L, Clausen O, et al. A study of phosphorylated ERK1/2 and COX-2 in early stage (T1-T2) oral squamous cell carcinomas. J Oral Pathol Med. 2008;37:535-42 pubmed publisher
  56. Rauh Adelmann C, Moskow J, Graham J, Yen L, Boucher J, Murphy C, et al. Quantitative measurement of epidermal growth factor receptor-mitogen-activated protein kinase signal transduction using a nine-plex, peptide-based immunoassay. Anal Biochem. 2008;375:255-64 pubmed publisher
  57. Klees R, Salasznyk R, Ward D, Crone D, Williams W, Harris M, et al. Dissection of the osteogenic effects of laminin-332 utilizing specific LG domains: LG3 induces osteogenic differentiation, but not mineralization. Exp Cell Res. 2008;314:763-73 pubmed publisher
  58. Salasznyk R, Klees R, Boskey A, Plopper G. Activation of FAK is necessary for the osteogenic differentiation of human mesenchymal stem cells on laminin-5. J Cell Biochem. 2007;100:499-514 pubmed
  59. Hao H, Schwaber J. Epidermal growth factor receptor induced Erk phosphorylation in the suprachiasmatic nucleus. Brain Res. 2006;1088:45-8 pubmed
  60. Carulli M, Ong V, Ponticos M, Shiwen X, Abraham D, Black C, et al. Chemokine receptor CCR2 expression by systemic sclerosis fibroblasts: evidence for autocrine regulation of myofibroblast differentiation. Arthritis Rheum. 2005;52:3772-82 pubmed